Product Data Sheet

SalA-VS-08

Catalog No. A62518

main product photo
SalA-VS-08 is a full agonist of the kappa-opioid receptor (KOR) known for its selectivity and G-protein bias. This compound exhibits significant analgesic activity, making it a valuable tool for research into pain management and opioid receptor signaling. SalA-VS-08 can be utilized in studies investigating the therapeutic potential of KOR activation in various pain conditions.
Chemical Information
Catalog NumA62518
M. Wt396.46
FormulaC22H25FN4O2
Purity>98%
Storageat -20 °C 3 years (powder form); at -20 °C 6 months (Solution base)
CAS No.2439152-14-2
Synonyms
SMILESO=C(C1)N(CC2CC2)C3=CC(C)=NN3C41CCN(C(C5=CC=CC(F)=C5)=O)CC4
Biological Activity
DescriptionSalA-VS-08 is a full agonist of the kappa-opioid receptor (KOR) known for its selectivity and G-protein bias. This compound exhibits significant analgesic activity, making it a valuable tool for research into pain management and opioid receptor signaling. SalA-VS-08 can be utilized in studies investigating the therapeutic potential of KOR activation in various pain conditions.
RETURN POLICY
Adooq’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Adooq products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Adooq Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Adooq products are stable under the recommended conditions.